XML 31 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
C. STOCKHOLDERS EQUITY (Tables)
6 Months Ended
Mar. 31, 2014
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company
    Total     Shares              
    Shares     Reserved for     Shares     Remaining  
     Reserved      Outstanding      Issued as      Options/Shares  
Name of Plan     Under Plans      Options      Stock Bonus      Under Plans  
Incentive Stock Option Plans     1,960,000       1,573,597       N/A       145,703  
Non-Qualified Stock Option                          
   Plans     5,680,000       4,417,584       N/A       700,497  
Stock Bonus Plans     1,594,000       N/A       983,866       609,378  
Stock Compensation Plan     1,350,000       N/A       893,637       456,363  
Schedule of employees and non-employees stock compensation

 

 

    Six Months Ended March 31,  
    2014     2013  
             
 Employees   $ 1,030,429     $ 1,523,349  
 Non-employees   $ 421,509     $ 208,355  

 

    Three Months Ended March 31,  
    2014     2013  
             
 Employees   $ 520,151     $ 556,764  
 Non-employees   $ 206,789     $ 100,537  
Derivative Liabilities, Warrants and Other Options
Warrant Issue Date   Shares Issuable upon Exercise of Warrant     Exercise Price   Expiration Date   Reference  
                       
Series N 8/18/08     2,844,627       0.53   8/18/15     1  
Series A 6/24/09     130,347       5.00   12/24/14     1  
Schleuning (Series A) 7/8/09     16,750       5.00   1/8/15     1  
Series B 9/4/09     50,000       6.80   9/4/14     1  
Series C 8/20/09 – 8/26/09     463,487       5.50   2/20/15     1  
Series E 9/21/09     71,428       17.50   8/12/14     1  
Series F 10/6/11     1,200,000       4.00   10/6/14     1  
Series G 10/6/11     66,667       4.00   8/12/14     1  
Series H 1/26/12     1,200,000       5.00   8/1/15     1  
Series Q 6/21/12     1,200,000       5.00   12/22/15     1  
Series R 12/6/12     2,625,000       4.00   12/6/16     1  
Series S 10/11/13-12/24/13     24,111,983       1.25   10/11/18     1  
                             
Series L 4/18/07     25,000       7.50   4/17/14     2  
Series L (repriced) 4/18/07     70,000       2.50   4/2/15     2  
Series M (modified) 4/18/07     -       1.00   4/20/14     2  
                             
Series P 2/10/12     590,001       4.50   3/6/17     3  
                             
Private Investors 7/18/05- 5/18/06     117,500       6.50-8.20   5/17/14 - 7/18/14     4  
                             
Warrants held by Officer and Director 6/24/09-7/6/09     349,754       4.00 – 5.00   12/24/14 – 1/6/15     5  
                             
Consultants 2/15/05-10/28/13     200,750       0.85-20.00   5/20/14 - 12/27/17     6  
Tabular disclosure of derivative liabilities at fair value
    March 31, 2014     September 30, 2013  
             
Series A through E warrants   $ 30,529     $ 6,106  
Series N warrants     -       41,501  
Series F and G warrants     49,333       12,667  
Series H warrants     72,000       36,000  
Series Q warrants     120,000       48,000  
Series R warrants     472,500       288,750  
Series S warrants     10,247,593       -  
                 
Total derivative liabilities   $ 10,991,955     $ 433,024